Segment Reporting and Foreign Operations (Tables)

12 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Schedule of Long-lived Assets by Geographic Area

Our long-lived assets (which are comprised of our net property, plant and equipment) by geographic area at December 31, 2019, 2018 and 2017, consisted of the following (in thousands):

	2019		2018		2017
United States	$	273,816	$	231,864	$	202,504
Ireland		44,912		45,283		45,671
Other foreign countries		60,057		54,305		44,645
Total	$	378,785	$	331,452	$	292,820

Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the years ended December 31, 2019, 2018 and 2017, are as follows (in thousands):

	2019		2018		2017
Net Sales
Cardiovascular	$	960,981	$	849,477	$	700,613
Endoscopy		33,871		33,276		27,239
Total net sales		994,852		882,753		727,852
Operating Expenses
Cardiovascular		382,313		321,461		281,095
Endoscopy		34,619		14,692		12,089
Total operating expenses		416,932		336,153		293,184
Operating Income
Cardiovascular		25,780		49,289		24,819
Endoscopy		(10,346)		9,328		8,250
Total operating income		15,434		58,617		33,069
Total other income (expense) - net		(13,241)		(9,098)		2,812
Income tax expense (benefit)		(3,258)		7,502		8,358
Net income	$	5,451	$	42,017	$	27,523

Total assets by business segment at December 31, 2019, 2018 and 2017, consisted of the following (in thousands):

	2019		2018		2017
Cardiovascular	$	1,745,057	$	1,588,970	$	1,103,806
Endoscopy		12,264		31,042		8,005
Total	$	1,757,321	$	1,620,012	$	1,111,811

Total depreciation and amortization by business segment for the years ended December 31, 2019, 2018 and 2017 consisted of the following (in thousands):

	2019		2018		2017
Cardiovascular	$	91,151	$	68,722	$	52,700
Endoscopy		949		824		882
Total	$	92,100	$	69,546	$	53,582

Total capital expenditures for property and equipment by business segment for the years ended December 31, 2019, 2018 and 2017 consisted of the following (in thousands):

	2019		2018		2017
Cardiovascular	$	77,631	$	63,032	$	38,437
Endoscopy		542		292		186
Total	$	78,173	$	63,324	$	38,623

Reconciliation of Assets from Segment to Consolidated

	2019		2018		2017
Net Sales
Cardiovascular	$	960,981	$	849,477	$	700,613
Endoscopy		33,871		33,276		27,239
Total net sales		994,852		882,753		727,852
Operating Expenses
Cardiovascular		382,313		321,461		281,095
Endoscopy		34,619		14,692		12,089
Total operating expenses		416,932		336,153		293,184
Operating Income
Cardiovascular		25,780		49,289		24,819
Endoscopy		(10,346)		9,328		8,250
Total operating income		15,434		58,617		33,069
Total other income (expense) - net		(13,241)		(9,098)		2,812
Income tax expense (benefit)		(3,258)		7,502		8,358
Net income	$	5,451	$	42,017	$	27,523